Collegium Pharmaceutical, Inc. (COLL) earnings per share (EPS)

Earnings per share · fiscal 2025
$1.73

Collegium Pharmaceutical, Inc. (COLL) reported diluted earnings per share of $1.73 in fiscal 2025 (the year ended December 31, 2025). That is 7.0% lower than the $1.86 of fiscal 2024. Figures as of 17 Nov 2026, 20:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$1.73
Change on fiscal 2024
−7.0%
Growth, 5 years
+17.9% a year
Highest on record
$1.86fiscal 2021
Lowest on record
-$22.72fiscal 2014
Fiscal years on record
112014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Collegium Pharmaceutical, Inc. earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 17.9% a year. Across the 11 fiscal years on record (2014–2025), the highest was $1.86 in fiscal 2021 and the lowest -$22.72 in fiscal 2014.

History · 11 fiscal years

Earnings per share by fiscal year

Collegium Pharmaceutical, Inc. earnings per share (EPS), year by year

Collegium Pharmaceutical, Inc. (COLL) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$1.73 7.0% down
2024$1.86 44.2% up
2023$1.29—
2022-$0.74 139.8% down
2021$1.86 144.7% up
2020$0.76—
2019-$0.68—
2018-$1.19—
2016-$3.88—
2015-$1.48—
2014-$22.72—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on COLL

Collegium Pharmaceutical, Inc., figure by figure

Collegium Pharmaceutical, Inc. (COLL) overview: price, valuation and scorecard

Collegium Pharmaceutical, Inc. earnings per share (EPS): questions and answers

What is Collegium Pharmaceutical, Inc.'s diluted earnings per share?

Collegium Pharmaceutical, Inc. (COLL) reported diluted earnings per share of $1.73 in fiscal 2025 (the year ended December 31, 2025). That is 7.0% lower than the $1.86 of fiscal 2024.

What is the growth rate of Collegium Pharmaceutical, Inc.'s diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 17.9% a year.

What are the highest and lowest diluted earnings per share figures on record for Collegium Pharmaceutical, Inc.?

Across the 11 fiscal years on record (2014–2025), the highest was $1.86 in fiscal 2021 and the lowest -$22.72 in fiscal 2014.

How is Collegium Pharmaceutical, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Collegium Pharmaceutical, Inc. (COLL) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/COLL/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.